14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:AIMT
Delisted

Aimmune Therapeutics Stock Price (Quote)

$34.49
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $34.49 $34.49 Friday, 27th May 2022 AIMT stock ended at $34.49. During the day the stock fluctuated 0% from a day low at $34.49 to a day high of $34.49.
90 days $34.49 $34.49
52 weeks $34.49 $34.49

Historical Aimmune Therapeutics prices

Date Open High Low Close Volume
Jan 10, 2020 $32.39 $32.50 $31.11 $31.25 1 283 899
Jan 09, 2020 $34.41 $34.43 $31.34 $31.40 1 885 112
Jan 08, 2020 $34.22 $34.71 $34.19 $34.28 703 950
Jan 07, 2020 $34.99 $35.26 $34.15 $34.30 759 123
Jan 06, 2020 $34.88 $35.48 $34.06 $34.68 1 278 297
Jan 03, 2020 $34.75 $35.47 $34.50 $35.09 1 021 494
Jan 02, 2020 $33.88 $35.42 $33.53 $35.01 1 218 688
Dec 31, 2019 $33.59 $33.80 $32.80 $33.47 927 926
Dec 30, 2019 $32.84 $33.67 $32.40 $33.53 1 206 491
Dec 27, 2019 $33.60 $33.89 $32.50 $32.68 857 580
Dec 26, 2019 $33.31 $33.94 $32.44 $33.21 899 884
Dec 24, 2019 $32.35 $32.70 $31.99 $32.64 385 744
Dec 23, 2019 $31.60 $32.32 $31.14 $32.09 704 397
Dec 20, 2019 $31.60 $31.75 $30.72 $31.55 1 489 391
Dec 19, 2019 $31.92 $31.98 $31.33 $31.60 583 764
Dec 18, 2019 $31.96 $32.13 $31.33 $31.61 482 615
Dec 17, 2019 $31.89 $31.89 $31.35 $31.68 701 068
Dec 16, 2019 $31.50 $32.09 $31.40 $31.61 838 357
Dec 13, 2019 $30.59 $31.50 $30.26 $31.30 859 642
Dec 12, 2019 $30.87 $31.97 $30.87 $31.59 631 847
Dec 11, 2019 $31.87 $32.22 $30.61 $30.79 1 008 763
Dec 10, 2019 $29.98 $31.90 $29.91 $31.88 1 080 017
Dec 09, 2019 $30.60 $30.60 $29.58 $30.09 835 777
Dec 06, 2019 $29.29 $29.70 $29.02 $29.65 456 516
Dec 05, 2019 $29.48 $29.63 $28.92 $29.13 426 778
Click to get the best stock tips daily for free!

About Aimmune Therapeutics

Aimmune Therapeutics Aimmune Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of desensitization treatments for peanut and other food allergies. Its Characterized Oral Desensitization Immunotherapy includes AR101, a product in Phase 3 registration trial for the treatment of peanut allergy in children and adults. The company was formerly known as Allergen Research Corporation and changed its name to Aimmune Therapeutics, Inc. ... AIMT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT